By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IsoRay, Inc. 

350 Hills Street
Suite 106
Richland  Washington  99354  U.S.A.
Phone: 509-375-1202 Fax:


Medical Device

Company News
IsoRay (ISR) Announces Final Court Approval Of Class Action Settlement 3/10/2017 8:06:10 AM
IsoRay (ISR) Announces Second Quarter Fiscal 2017 Financial Results 2/9/2017 9:28:27 AM
IsoRay (ISR) Announces The Launch Of A Pilot Study Using Intraoperative Placement Of Cesium-131 Permanent Interstitial Brachytherapy In Resectable High Risk Recurrent Head And Neck Cancer By Case Comprehensive Cancer Center 12/21/2016 11:56:18 AM
IsoRay (ISR) Announces "Cesium-131 Brachytherapy For Salvage Of Recurrent High Grade Glioma" Poster Presentation At 21st Annual Scientific Meeting Of Society For Neuro-Oncology 11/29/2016 11:33:31 AM
IsoRay (ISR) Announces First Quarter Fiscal 2017 Financial Results 11/9/2016 10:13:12 AM
IsoRay (ISR) Announces Date For Fiscal 2017 Annual Meeting And Shareholder Record Date 10/21/2016 7:44:19 AM
IsoRay (ISR) Announces Launch Of Newly Redesigned Patient And Clinician Focused Corporate Website 9/28/2016 8:12:11 AM
IsoRay (ISR) Enters Into Agreement To Settle Class Action Shareholder Litigation 9/27/2016 7:32:13 AM
IsoRay (ISR) Announces Fourth Quarter And Year End Fiscal 2016 Financial Results 9/9/2016 7:24:59 AM
IsoRay (ISR) To Present At Rodman & Renshaw 18th Annual Global Investment Conference 8/16/2016 12:18:06 PM